IRCT20171118037528N1已完成2 期
Effects of resveratrol on lipid and glycemic profile indices, expression of PPARa, some factors associated with cell cycle arrest and sCD163 to sTWEAK ration in T2DM patients.
Yazd University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 60 years（—）
- 性别
- All
入选标准
- •Male and female subjects with established T2DM, who have been diagnosed for at least three months
- •who have body mass index between 24-30 kgm2,
- •and aged 30-60 years,
排除标准
- •clinical diagnosis of any liver, kidney, cancer and Alzheimer's diseases
- •insulin therapy;
- •consumption of any antioxidant supplements in the last six months
- •history of allergic reaction to grapes;
- •consumption of anticoagulants, fibrates and aspirin
- •drinking red wine and alcohol
- •history of myocardial infraction
- •presence of stent or battery in the heart
- •gastrointestinal ulcer
- •pregnancy or lactation;
- •follow the unusual diet until one month before the study;
- •unwillingness to participation in study
研究者
相似试验
已完成
不适用
Effect of resveratrol on insulin sensitivity and metabolic profile in type 2 diabeticsobesitas and sugar1001842410013317NL-OMON37515niversiteit Maastricht24
Unknown
不适用
Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass SurgeryObesityNCT01826279University of Aarhus16
已完成
3 期
The effect of resveratrol on anti-HIV hyperglycemiaIRCT20180114038356N2Kermanshah University of Medical Sciences80
已完成
2 期
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic SteatohepatitisNon Alcoholic Fatty LiverNCT02030977Dr Azita Hekmatdoost50
已完成
2 期
Effect of supplementation in treatment of Coronary Heart DiseaseCoronary Heart Disease.Chronic ischemic heart disease, unspecifiedI25.9IRCT20181029041490N1Kashan University of Medical Sciences60